FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Press/Media

Period	7 Nov 2024

Media coverage

Title	FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
Media name/outlet	Hospitals-Management.com
Country/Territory	United States
Date	7/11/24
URL	https://www.hospitals-management.com/pressreleases/fda-grants-breakthrough-device-designation-for-seastar-medicals-selective-cytopheretic-device-for-adults-undergoing-chronic-dialysis
Persons	Kevin Chung